Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 247
- +15 vs. Q3 2024
- Shares held
- 99.7M
- +15.3M (+18.2%) vs. Q3 2024
- Total value
- $5.10B
- +$783.6M (+18.2%) vs. Q3 2024
- New holders
- 37
- 111 more added
- Sold out
- 22
- 68 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 334,783 | $17.1M | 0.03% | +334,783 | New |
| Bank of New York Mellon Corp | 344,765 | $17.6M | 0.00% | +32,825+10.5% | Added |
| Ameriprise Financial Inc | 355,174 | $18.2M | 0.00% | +186,681+110.8% | Added |
| Voya Investment Management LLC | 389,220 | $19.9M | 0.02% | +582+0.1% | Added |
| Schonfeld Strategic Advisors LLC | 445,946 | $22.8M | 0.14% | −44,779−9.1% | Reduced |
| First Turn Management, LLC | 453,376 | $23.2M | 4.15% | +100,000+28.3% | Added |
| Fiera Capital Corp | 454,982 | $23.3M | 0.07% | −11,093−2.4% | Reduced |
| Affinity Asset Advisors, LLC | 460,000 | $23.5M | 3.67% | +60,000+15.0% | Added |
| American Century Companies Inc | 477,298 | $24.4M | 0.01% | +90,412+23.4% | Added |
| Ensign Peak Advisors, Inc | 502,690 | $25.7M | 0.05% | −114,147−18.5% | Reduced |
| Morgan Stanley | 505,040 | $25.8M | 0.00% | −160,559−24.1% | Reduced |
| Ikarian Capital, LLC | 516,431 | $26.4M | 7.54% | +89,518+21.0% | Added |
| Nuveen Asset Management, LLC | 527,792 | $27.0M | 0.01% | +13,598+2.6% | Added |
| SG Americas Securities, LLC | 542,446 | $27.7M | 0.12% | +529,483+4,084.6% | Added |
| Fisher Asset Management, LLC | 559,287 | $28.6M | 0.01% | +77,188+16.0% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 576,068 | $29.5M | 0.07% | +84,687+17.2% | Added |
| Eventide Asset Management, LLC | 609,014 | $31.1M | 0.57% | −126,074−17.2% | Reduced |
| MPM Oncology Impact Management LP | 617,035 | $31.5M | 4.48% | +91,190+17.3% | Added |
| GW&K Investment Management, LLC | 679,123 | $34.7M | 0.30% | −53,769−7.3% | Reduced |
| UBS Group AG | 707,730 | $36.2M | 0.01% | +524,844+287.0% | Added |
| Goldman Sachs Group Inc | 721,269 | $36.9M | 0.01% | −65,759−8.4% | Reduced |
| Lord, Abbett & Co. LLC | 724,625 | $37.0M | 0.12% | −21,493−2.9% | Reduced |
| Charles Schwab Investment Management Inc | 759,126 | $38.8M | 0.01% | +103,708+15.8% | Added |
| Pictet Asset Management Holding SA | 848,050 | $43.4M | 0.05% | −60,099−6.6% | Reduced |
| Hood River Capital Management LLC | 851,400 | $43.5M | 0.64% | +16,488+2.0% | Added |
| Northern Trust Corp | 879,814 | $45.0M | 0.01% | +149,298+20.4% | Added |
| First Light Asset Management, LLC | 885,453 | $45.3M | 4.33% | −58,158−6.2% | Reduced |
| Novo Holdings A/S | 960,215 | $49.1M | 2.97% | −39,785−4.0% | Reduced |
| OrbiMed Advisors LLC | 999,000 | $51.1M | 1.06% | −51,055−4.9% | Reduced |
| Cormorant Asset Management, LP | 1,000,000 | $51.1M | 2.81% | −100,000−9.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,002,882 | $51.3M | 0.03% | −65,650−6.1% | Reduced |
| Franklin Resources Inc | 1,591,666 | $81.4M | 0.02% | +201,556+14.5% | Added |
| Siren, L.L.C. | 1,609,652 | $82.3M | 3.64% | +300,000+22.9% | Added |
| Paradigm Biocapital Advisors LP | 1,910,761 | $97.7M | 3.40% | −605,925−24.1% | Reduced |
| Geode Capital Management, LLC | 2,098,841 | $107.3M | 0.01% | +250,708+13.6% | Added |
| Jennison Associates LLC | 2,708,351 | $138.5M | 0.08% | −85,263−3.1% | Reduced |
| Point72 Asset Management, L.P. | 2,788,939 | $142.6M | 0.39% | +488,296+21.2% | Added |
| Janus Henderson Group PLC | 2,795,441 | $142.9M | 0.07% | +365,991+15.1% | Added |
| State Street Corp | 2,990,838 | $152.9M | 0.01% | +152,354+5.4% | Added |
| Farallon Capital Management, L.L.C. | 4,075,098 | $208.4M | 1.10% | +2,913,098+250.7% | Added |
| EcoR1 Capital, LLC | 4,288,120 | $219.3M | 8.78% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 5,414,505 | $276.8M | 0.03% | +469,748+9.5% | Added |
| Driehaus Capital Management LLC | 6,141,014 | $314.0M | 2.59% | +255,766+4.3% | Added |
| Wellington Management Group LLP | 6,950,567 | $355.4M | 0.07% | +2,490,876+55.9% | Added |
| BlackRock, Inc. | 7,515,193 | $384.3M | 0.01% | +965,251+14.7% | Added |
| FMR LLC | 8,928,086 | $456.5M | 0.03% | +4,472,316+100.4% | Added |
| Vanguard Group Inc | 9,089,391 | $464.7M | 0.01% | +2,801,736+44.6% | Added |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −392,196−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −205,000−100.0% | Sold out |
| Maplelane Capital, LLC | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| Senator Investment Group LP | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −103,927−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −100,188−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −62,679−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −57,216−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −53,042−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −34,646−100.0% | Sold out |
| Advantage Alpha Capital Partners LP | 0 | $0 | 0.00% | −8,640−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −6,727−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −6,684−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −5,414−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,717−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,786−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −1,644−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |